Skip to main content

Advertisement

Table 1 Demographics and clinic-pathologic characteristics (n = 139)

From: Impact of preoperative risk factors on outcome after gastrectomy

CharacteristicsNumber of patientsPercentage
Preoperative tumor findings
 Mean age64 (24–91) years old
 Gender
  Male9669.1%
  Female4330.9%
 Localization
  Cardia3827.3%
  Corpus5539.2%
  Fundus32.2%
  Antrum/pylorus4330.9%
 Histology
  Adenocarcinoma13899.3%
  Adenosquamous carcinoma10.7%
 Laurén-classification
  Intestinal5438.8%
  Diffuse5841.7%
  Mixed128.6%
 Tumor stage
  uT11611.5%
  uT23827.3%
  uT37251.8%
  uT496.5%
 Nodal stage
  uN positive6949.6%
  uN negative6949.6%
 Metastasis
  M012690.6%
  M1117.9%
  Mx21.4%
 Mean tumor size3 (0.2–30) cm
 Neoadjuvant therapy
  Yes5741%
  No8259%
Treatment
 Response to neoadjuvant therapy (n = 57)
  Clinical response (yes)4375.4%
  Clinical response (no)1424.6%
  Pathologic response (yes)3154%
  Pathologic response (no)2645.6%
 Intention
  Curative12086.3%
  Palliative1913.7%
 Timing
  Elective13899.3%
  Emergency10.7%
 Procedure
  Subtotal3223%
  Gastrectomy8259%
  Extended2518%
 Intraoperative blood loss
  ≤ 100 ml4129.5%
  101–500 ml6647.5%
  501–1000 ml2920.9%
  ≥ 1001 ml32.2%
 Anastomosis
  Stapler9669.1%
  Hand suture4330.9%
Postoperative tumor findings
 Tumor stage
  (y)pT064.3%
  (y)pTis10.7%
  (y)pT12618.7%
  (y)pT23021.6%
  (y)pT34733.8%
  (y)pT42920.9%
 Nodal stage
  N06244.6%
  N13525.2%
  N21611.5%
  N32618.7%
 Metastasis
  M012287.8%
  M11510.8%
 Resection margin
  R012287.8%
  R11510.8%
  R221.4%
 Histological grading
  G075%
  G142.9%
  G22518%
  G39366.9%
 Lymph nodes removed (mean)23 (4–60)
  Lymph node invasion
  L08762.6%
  L14532.4%
 Invasion into vein
  V011381.3%
  V11913.7%
Median hospital stay (range)14 (1–120) days
In-hospital mortality42.9%
Survival rate5.6 years
Recurrence (n = 120)
 Yes4136.9%
 No6962.2%
Recurrence-free survival3.4 years